Purdue Pharma Says Settlement Talks in Opioid Cases Not Over

In this Friday, Aug. 17, 2018, file photo, Christine Gagnon of Southington, Conn., protests with other family and friends who have lost loved ones to OxyContin and opioid overdoses at Purdue Pharma LLP headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation’s deadly overdose crisis hit an impasse, attorneys general involved in the talks said Saturday, Sept. 7, 2019, in a message to their counterparts across the country. (AP Photo/Jessica Hill, File)   OxyContin maker Purdue Pharma and lawyers representing local governments both said Sunday that they're interested in continuing negotiations to settle lawsuits over the toll of the opioid crisis a day after two state attorneys general told colleagues that their talks with the company were at an impasse and that they expected the company to file imminently for bankruptcy. The statements add another layer of uncertainty to attempts to strike a deal with a company that's portrayed as a prime villain in the national opioid crisis. In a statement, the company said, "negotiations continue and we remain dedicated to a resolution that genuinely advances the public interest." The company said it is prepared to defend itself in litigation, but that "Purdue Pharma believes a settlement that benefits the American public now is a far better path than years of wasteful litigation and appeals.&quo...
Source: JEMS Patient Care - Category: Emergency Medicine Tags: News Patient Care AP News Tag Source Type: news